Perioperative interdisciplinary optimisation of patients with heart failure undergoing non-cardiac surgery with intermediate or high surgical risk: the rationale and study protocol for the multicentre, randomised interventional PeriOP-CARE HF trial
- PMID: 40299034
- PMCID: PMC12058920
- DOI: 10.1007/s00392-025-02626-3
Perioperative interdisciplinary optimisation of patients with heart failure undergoing non-cardiac surgery with intermediate or high surgical risk: the rationale and study protocol for the multicentre, randomised interventional PeriOP-CARE HF trial
Abstract
Aim: Chronic heart failure (HF) is a frequent comorbidity in elderly patients undergoing major non-cardiac surgery with increasing prevalence. This trial aims to evaluate a new interdisciplinary, multimodal and individually optimised treatment strategy in patients with established or at risk for HF throughout the entire perioperative period.
Methods: The PeriOP-CARE HF trial is a prospective, multicentre, randomised, controlled and interventional trial. The primary hypothesis is that an interdisciplinary, intersectoral and standardised approach to the preoperative evaluation, optimisation and perioperative management of patients aged ≥ 65 years undergoing non-cardiac surgery with intermediate or high surgical risk and preoperative N-terminal pro-brain natriuretic peptide levels ≥ 450 pg/mL, will reduce postoperative morbidity. The preoperative evaluation includes clinical evaluations by anaesthesiologists and cardiologists, electrocardiography and echocardiography, as well as a discussion of these findings by a perioperative management team, where all involved specialities, including the speciality surgeon, will decide the perioperative treatment strategy for each patient. Intraoperative strategies include individualised haemodynamic optimisation. The interdisciplinary team and specialised HF nurses will screen patients for HF-related postoperative complications. The primary end point will be a composite morbidity end point, comprising any rehospitalisation, acute kidney injury, suspected or proven bacterial infection requiring treatment and acute decompensated HF at postoperative day 90.
Conclusion: The new treatment form can potentially reduce the morbidity burden after major non-cardiac surgery in patients with known or unknown HF. If the PeriOP-CARE HF trial yields positive results, the treatment of patients with HF undergoing major non-cardiac surgery could be considerably improved.
Trial registration: clinicaltrials.gov: NCT06381427, registered April 24, 2024.
Keywords: Acute decompensated heart failure; Acute kidney injury; Brain natriuretic peptide; Infection; Preoperative; Rehospitalisation.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. Ethical approval: The study was approved by the local ethics committee of the medical faculty of the Justus-Liebig-University, Giessen, Germany (AZ 73/22).
Figures
References
-
- Gualandro DM, Puelacher C, Chew MS, Andersson H, Lurati Buse G, Glarner N et al (2023) Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes. Eur J Heart Fail 25:347–357. 10.1002/ejhf.2773 - PubMed
-
- Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E et al (2022) ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 10.1093/eurheartj/ehac270 - PubMed
-
- Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T et al (2004) Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death. N Engl J Med 350:655–663. 10.1056/nejmoa031994 - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous